Tumour Trace’s peer reviewed, award winning and patented technology is capable of diagnosing multiple forms of cancer within minutes at the point of care, at accuracy better than current standards for an order of magnitude less cost. The method called opto-magnetic imaging spectroscopy uses a light probe to detect magnetic fields around hydrogen co-valent bonds, has been validated in pre-clinical trials for cervical, bowel, prostate and oral cancers.
Company’s Keywords:
<2
<
<2014
Your request has been submitted successfully.
Own or work here?